Federal Supply Schedule V797P2204D

This Federal Supply Schedule contract was awarded by the U.S. Department of Veterans Affairs' Veterans Integrated Service Network 12 to Hema Biologics LLC, a for-profit limited liability company. The contract is for the procurement of pharmaceutical and hematology-related products under FSS Schedule 65 I B, with a ceiling value of $225,000 and a period of performance through September 14, 2026. The contracted products and services encompass a broad range of drugs, pharmaceuticals, and...

This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs (VA) to Agepha Pharma USA LLC, a foreign-owned, self-certified small disadvantaged business and woman-owned small business. The contract, under FSS Schedule 65 IB for Drugs, Pharmaceuticals, & Hematology Related Products, has a ceiling value of $25,000.00 and a period of performance through June 14, 2024. The purpose of this interim agreement is to provide the VA with access to a variety of pharmaceutical...

The Department of Veterans Affairs Veterans Health Administration awarded a multiple-award Federal Supply Schedule contract to Biocon Biologics Inc., a foreign-owned, for-profit manufacturer of goods. The contract provides an interim agreement under FSS Schedule 65 I B for drugs, pharmaceuticals, and hematology-related products. The potential value of the contract is $25 million. Delivery orders may be placed under the contract through February 2029. The contract facilitates procurement of...

This federal contract IDV is a multiple award Federal Supply Schedule (FSS) contract held by 60 Degrees Pharmaceuticals, Inc. to provide pharmaceutical and hematology products to the U.S. Department of Veterans Affairs (VA) under GSA Schedule 65IB. The contract has a 5-year period of performance and a $250,000 ceiling value, enabling VA medical centers in VISN 12 to procure hematology supplies without separate solicitations. 60 Degrees Pharmaceuticals also holds a separate $25,000 interim FSS...

This is a Federal Supply Schedule contract (FSS-61-IB) awarded by the Department of Veterans Affairs (VA) to Wockhardt USA LLC, a foreign-owned for-profit company. The contract has a ceiling value of $39,265,300 and a period of performance through June 30, 2025. The contract provides for the delivery of pharmaceutical and hematology-related products to the VA. The original solicitation and any subsequent task orders or price lists were not provided, so the specific products and services being...

This Federal Supply Schedule contract with the Department of Veterans Affairs (VA) is for the procurement of drugs, pharmaceuticals, and hematology-related products. The prime contractor is Biocon Biologics Inc., a foreign-owned for-profit manufacturer of goods. The contract has a ceiling value of $750,000.00 and a period of performance from March 1, 2024 to February 28, 2029. As a Federal Supply Schedule contract, this is a multiple award, indefinite delivery vehicle that allows federal...

This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government, to Vifor Pharma Inc., a foreign-owned for-profit organization. The contract has a period of performance from March 1, 2023 to February 28, 2028 and a ceiling value of $85,200,000.00. The contract provides for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B of the Federal Supply Schedules. This...

This Federal Supply Schedule contract, awarded by the Department of Veterans Affairs (VA), is for the procurement of 65IB, Drugs, Pharmaceuticals, & Hematology Related Products. The prime contractor is Shorla Oncology Inc., a for-profit, foreign-owned organization. The contract has a ceiling value of $250,000.00 and a period of performance from August 15, 2024 to August 14, 2029. The contract aims to provide the VA with a range of pharmaceutical and hematology-related products. While no...

The Federal Supply Schedule contract with ID 36F79723D0147 was awarded by the Department of Veterans Affairs to the prime contractor Immunogen Inc., a subsidiary of Abbvie Inc. The contract is classified under the FSS category "65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS" and has a total ceiling value of $225,000.00 with a period of performance through June 14, 2028. As a Federal Supply Schedule contract, this vehicle provides federal agencies with a streamlined...

This Federal Supply Schedule (FSS) contract was awarded by the Department of Veterans Affairs (VA) to NS Pharma, Inc., a foreign-owned for-profit manufacturer of pharmaceutical and hematology-related products. The contract, with a ceiling value of $225,000, has an ultimate completion date of March 14, 2026 and was originally awarded on March 15, 2021. The scope of the contract includes the provision of "Drugs, Pharmaceuticals, & Hematology Related Products" under the GSA Schedule...